Clinical Trial Update: A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS) [Phase 3]

View source ↗

Summary

This Phase 3 randomized, multi-center trial evaluated pimecrolimus-eluting and pimecrolimus/paclitaxel-eluting coronary stents and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease

Drugs mentioned

• Pimecrolimus-eluting coronary stent system (pimecrolimus)
• Pimecrolimus/Paclitaxel-eluting coronary stent system (pimecrolimus; paclitaxel)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Disease | Phase 3 | Status: COMPLETED